title: Is platelet transfusion the solution to reverse platelet inhibition in patients on triple antiplatelet therapy?
authors.affiliation: Faculté de pharmacie, Université de Montréal, C.P. 6128, succ. Centre-ville, Montréal, Québec H3C 3J7, Canada; Research Center, Montreal Heart Institute, 5000 rue Bélanger, Montréal, Québec H1T 1C8, Canada. Electronic address: marie.lordkipanidze@umontreal.ca.
authors.forename: Marie
authors.initials: M
authors.lastname: Lordkipanidzé
mesh_terms: D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects; D004359:Drug Therapy, Combination; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D017713:Platelet Transfusion; D013988:Ticlopidine / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin